Takeda Pharmaceutical Company Limited - Company & Market Research Reports

Home /
Companies /
Takeda Pharmaceutical Company Limited

Takeda Pharmaceuticals is the largest pharmaceutical company in Asia and a top 15 pharmaceutical company in the world. It provides products in various therapeutic areas, including gastroenterology, oncology, central nervous system, cardiovascular and metabolic, vaccines, and others. Takeda was founded in 1781 and operates two primary bases in Japan in Osaka and Tokyo. Its global operations are based in Zurich, Switzerland.

REFINE BY

KEYWORD

CATEGORIES

Oncology Drugs 190
Endocrine and Metabolic Disorders Drugs 166
Gastrointestinal Drugs 148
Immune Disorders Drugs 129
Central Nervous System Drugs 128
Biopharmaceuticals 88
Pharmaceuticals 84
Hematological Drugs 79
Vaccines 77
Clinical Trials 67
Drug Discovery 63
Cardiovascular Drugs 60
Diabetes Drugs 56
Infectious Diseases Drugs 53
Leukemia Drugs 53
Mental Disorders Drugs 46
Lymphoma Drugs 42
Musculoskeletal Disorders Drugs 41
Liver and Kidney Disorders Drugs 32
Infusions and Injectables 31
Over the Counter (OTC) Drugs 30
Lung Cancer Drugs 24
Sexual and Reproductive Health Drugs 20
Drug Delivery 19
Respiratory Drugs 18
Pharmaceutical Manufacturing 17
Antibiotics 16
Analgesics 15
Drugs by Therapeutic Area 13
Immunosuppressive Drugs 13
Pharmaceutical Intermediates 12
Schizophrenia Drugs 12
Prostate Cancer Drugs 11
Skin Cancer Drugs 11
Optical Disorders Drugs 10
Anti-Obesity Drugs 9
Alzheimer's Disease Drugs 9
Generic Drugs 7
Biosimilars and Biosuperiors 7
Psoriasis Drugs 7
Addiction Disorders Drugs 6
Animal Pharmaceuticals 6
Colon Cancer Drugs 6
Transdermal and Transmucosal Drug Delivery 6
Thyroid Cancer Drugs 6
Uterine Cancer Drugs 6
Dermatological Drugs 6
Urological Disorders Drugs 6
Liver Cancer Drugs 4
Cervical Cancer Drugs 4
Brain Cancer Drugs 4
Cough and Cold Drugs 4
Company Reports 3
Breast Cancer Drugs 3
Kidney Cancer Drugs 3
HIV/AIDS Drugs 3
Ovarian Cancer Drugs 2
Anesthetic Drugs 2
Cancer Vaccines 2
Pancreatic Cancer Drugs 2
Vitamins and Dietary Supplements 2
Pharmacoeconomics 1
Inhalers and Nebulisers 1
Anxiety Drugs 1
Bronchitis Drugs 1

SHOW ALL

REPORT TYPE

All Reports

Company Reports

Market Reports

Google Reviews

4.8



285 reviews

1,651 Results (Page 49 of 83)
- Relevance
  Sort by

Ophthalmic Drugs Market - Global Forecast 2026-2032

 Report
September 2026
185 Pages
Global

From

€3153EUR$3,545USD£2,707GBP

€3503EUR$3,939USD£3,008GBP

Glaucoma Treatment Market - Global Forecast 2026-2032

 Report
September 2026
188 Pages
Global

From

€3153EUR$3,545USD£2,707GBP

€3503EUR$3,939USD£3,008GBP

Liposome Drug Delivery - Market Share Analysis, Industry Trends & Statistics, Growth Forecasts (2026-2031)

 Report
August 2026
111 Pages
Global

From

€4225EUR$4,750USD£3,627GBP

Dry Eye Syndrome Market - Global Forecast 2026-2032

 Report
September 2026
189 Pages
Global

From

€3153EUR$3,545USD£2,707GBP

€3503EUR$3,939USD£3,008GBP

Cancer Biologics Market Report 2023-2033

 Report
June 2023
308 Pages
Global

From

€4762EUR$5,542USD£3,950GBP

NEED HELP FINDING THE RIGHT PRODUCT? Brian will help you find what you are looking for.

Call: 1-800-526-8630 ASK A QUESTION REQUEST A CALL BACK

G8 Countries Pharmaceuticals Market Summary, Competitive Analysis and Forecast, 2018-2027

 Report
October 2023
228 Pages
Global

From

€1330EUR$1,495USD£1,141GBP

Gastrointestinal Diseases Therapeutics Market 2025-2029

 Report
June 2025
215 Pages
Global

From

€2223EUR$2,500USD£1,909GBP

Germany Over-the-Counter Drugs - Market Share Analysis, Industry Trends & Statistics, Growth Forecasts (2026-2031)

 Report
August 2026
80 Pages
Germany

From

€4225EUR$4,750USD£3,627GBP

Vaccine Research Market 2024-2028

 Report
August 2024
170 Pages
Global

From

€2223EUR$2,500USD£1,909GBP

Chikungunya Fever Market - Global Strategic Business Report

 Report
September 2026
377 Pages
Global

From

€5203EUR$5,850USD£4,467GBP

Cutaneous and Systemic Leishmaniasis Market - Global Strategic Business Report

 Report
September 2026
473 Pages
Global

From

€5203EUR$5,850USD£4,467GBP

Cytomegalovirus (CMV) Treatment - Global Strategic Business Report

 Report
September 2026
384 Pages
Global

From

€5203EUR$5,850USD£4,467GBP

Leptospirosis Market - Global Strategic Business Report

 Report
September 2026
382 Pages
Global

From

€5203EUR$5,850USD£4,467GBP

Neglected Tropical Disease Treatment - Global Strategic Business Report

 Report
September 2026
294 Pages
Global

From

€5203EUR$5,850USD£4,467GBP

Human Microbiome Therapeutics Market 2026-2030

 Report
June 2026
297 Pages
Global

From

€2223EUR$2,500USD£1,909GBP

Japan Contract Development & Manufacturing Organizations Market Size, Share & Trends Analysis Report by Product (API, Drug Product), Workflow, Application (Oncology, Hormonal, Glaucoma, CVD), Service, End-use with Growth Forecasts, 2025-2030

 Report
May 2025
127 Pages
Japan

From

€5292EUR$5,950USD£4,543GBP

LAMEA Head And Neck Cancer Therapeutics Market Size, Share & Industry Trends Analysis Report By Therapy Type (Immunotherapy, Chemotherapy, and Targeted Therapy), By Route of Administration, By Distribution Channel, By Country and Growth Forecast, 2022 - 2028

 Report
November 2022
86 Pages
Middle East, Africa

From

€1334EUR$1,500USD£1,145GBP

Europe Head And Neck Cancer Therapeutics Market Size, Share & Industry Trends Analysis Report By Therapy Type (Immunotherapy, Chemotherapy, and Targeted Therapy), By Route of Administration, By Distribution Channel, By Country and Growth Forecast, 2022 - 2028

 Report
November 2022
86 Pages
Europe

From

€1334EUR$1,500USD£1,145GBP

Asia Pacific Head And Neck Cancer Therapeutics Market Size, Share & Industry Trends Analysis Report By Therapy Type (Immunotherapy, Chemotherapy, and Targeted Therapy), By Route of Administration, By Distribution Channel, By Country and Growth Forecast, 2022 - 2028

 Report
November 2022
86 Pages
Asia Pacific

From

€1334EUR$1,500USD£1,145GBP

North America Head And Neck Cancer Therapeutics Market Size, Share & Industry Trends Analysis Report By Therapy Type (Immunotherapy, Chemotherapy, and Targeted Therapy), By Route of Administration, By Distribution Channel, By Country and Growth Forecast, 2022 - 2028

 Report
November 2022
77 Pages
North America

From

€1334EUR$1,500USD£1,145GBP

1,651 Results (Page 49 of 83)
- 1
- 47
- 48
- 49
- 50
- 51

ASK A QUESTION

An error occurred while sending the message. Should this issue persist, email us at help@researchandmarkets.net

*Required Information

Name*

Email Address* Please provide your business or academic email address.

Country*

Phone Number*

Your Question*

I have read Research and Markets' Privacy Policy and consent to the processing of my personal data.

We request your telephone number so we can contact you in the event we have difficulty reaching you via email. We aim to respond to all questions on the same business day.